@article{e274461509ac4646ba143fe17ccd6698,
title = "In reply—Strategies of Screening for Fabry Disease in Patients With Unexplained Left Ventricular Hypertrophy",
author = "Newman, {Darrell B.} and Ackerman, {Michael J.}",
note = "Funding Information: Potential Competing Interests: Dr Ackerman has served as a consultant for Audentes Therapeutics, Boston Scientific, Gilead Sciences, Invitae, Medtronic, MyoKardia, and St. Jude Medical. He is an employee of Mayo Clinic. He has received grants from the National Institutes of Health and royalties from AliveCor. The other author reports no competing interests. Potential Competing Interests: Dr Ackerman has served as a consultant for Audentes Therapeutics, Boston Scientific, Gilead Sciences, Invitae, Medtronic, MyoKardia, and St. Jude Medical. He is an employee of Mayo Clinic. He has received grants from the National Institutes of Health and royalties from AliveCor. The other author reports no competing interests. Funding Information: Potential Competing Interests: Dr Ackerman has served as a consultant for Audentes Therapeutics, Boston Scientific, Gilead Sciences, Invitae, Medtronic, MyoKardia, and St. Jude Medical. He is an employee of Mayo Clinic. He has received grants from the National Institutes of Health and royalties from AliveCor. The other author reports no competing interests. ",
year = "2019",
month = aug,
doi = "10.1016/j.mayocp.2019.05.004",
language = "English (US)",
volume = "94",
pages = "1646",
journal = "Mayo Clinic proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "8",
}